Poojary demands Tanvir Sait's resignation; UTK says party will decide

Bengaluru, Jul 12: KCTET 2020: Attention candidates, the Karnataka Deputy Chief Minister has confirmed the exam dates for Karnataka Common Entrance Test, KCET 2020.

As per information, KCET 2020 will be held between July 30 and July 31.

Karnataka Common Entrance Test or KCET is an examination which is held for admission to BTech courses in the state’s institutes.

The Higher Education Minister C N Ashwathnarayan, took to twitter to confirm the KCET dates. The Minister tweeted:

“The K-CET 2020 examinations will be held on the decided dates of July 30 & July 31. All the best to all the students!”

Details regarding KCET exam centers, time, and schedule will be mentioned in the admit card. Candidates can download their admit card fro the official website of KEA i.e. cetonline.karnataka.gov.in.

KCET 2020 was earlier scheduled to be held from April 22 to April 24, 2020, however, due to the ongoing coronavirus outbreak, KEA postponed KCET 2020 exams.

Bengaluru, May 3: The Commissioner of Health and Family Welfare Services in the government of Karnataka KA Dayanand issued an order approving quarantine of asymptomatic COVID-19 infected international passengers on payment basis at star hotels.

The international passengers in the state have been categorised into A, B and C groups depending on their symptoms and co-morbid conditions. Category A passengers are symptomatic and are being sent to isolation hospitals which may be COVID care centres.

Category B and C passengers are asymptomatic and are being sent to institutional facilities like hostels, guest houses, hotels, etc.

"On the basis of demands by category B and C passengers to provide them star hotel accommodation on a self-payment basis, they have been granted the choice of staying in those hotels at their own cost. The BBMP Special Commissioner/Deputy Commissioner can have a meeting with such hotels and finalise the negotiated rate," Commissioner Dayanand said in the order.

"The hotels for category B passengers should have round the clock presence of health personnel while hotels for category C passengers should be visited by health staff once a day," he added.

The United States of America has bought almost the entire world's supply of remdesivir, one of just two drugs proven to treat COVID-19. 

“President Trump has struck an amazing deal to ensure Americans have access to the first authorised therapeutic for Covid-19,” said the US health and human services secretary, Alex Azar. 

“To the extent possible, we want to ensure that any American patient who needs remdesivir can get it. The Trump administration is doing everything in our power to learn more about life-saving therapeutics for Covid-19 and secure access to these options for the American people.”

The announcement implies that no other country in the world will be able to buy remdesivir for next three months at least.

The anti-viral drug patented by the US-based Gilead biotech firm is the only one approved by the European Medicines Agency (EMA) to treat patients with the novel coronavirus.

The Trump administration has already shown that it is prepared to outbid and outmanoeuvre all other countries to secure the medical supplies it needs for the US.

“They’ve got access to most of the drug supply [of remdesivir], so there’s nothing for Europe,” said Dr Andrew Hill, senior visiting research fellow at Liverpool University.

Remdesivir, the first drug approved by licensing authorities in the US to treat Covid-19, is made by Gilead and has been shown to help people recover faster from the disease. 

The first 140,000 doses, supplied to drug trials around the world, have been used up. The Trump administration has now bought more than 500,000 doses, which is all of Gilead’s production for July and 90% of August and September.